Advertisement
Advertisement
IMCR
Immunocore Holdings plc - ADR
30.99
USDSponsored
+2.59
+9.12%
Nov 06, 15:59 UTC -5
Closed
After-Market
30.86
-0.13
-0.42%
Immunocore Holdings plc - ADR (IMCR) Earnings
IMCR Earnings Reports
Positive Surprise Ratio
IMCR beat 13 of 23 last estimates.
57%
Next Report
Date of Next Report
Feb 23, 2027
Estimate for Q4 26 (Revenue/ EPS)
$119.19M
/-$0.17
Implied change from Q3 26 (Revenue/ EPS)
--
/--
Implied change from Q4 25 (Revenue/ EPS)
+14.08%
/-71.67%
Immunocore Holdings plc - ADR earnings per share and revenue
On Nov 04, 2026, IMCR reported earnings of -- USD per share (EPS) for Q3 26, -- the estimate of -0.13 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 115.71 million, with a --% difference. The market reacted with a -2.66% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 11 analysts forecast an EPS of -0.17 USD, with revenue projected to reach 119.19 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Novavax Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.34
Actual
-$0.19
Surprise
+44.56%
Eton Pharmaceutcials, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.31
Actual
$1.06
Surprise
+232.50%
Castle Biosciences, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.37
Actual
-$0.13
Surprise
+65.32%
Monte Rosa Therapeutics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.29
Actual
$0.03
Surprise
+110.09%
PUMA BIOTECHNOLOGY INC
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.09
Actual
$0.15
Surprise
+63.40%
Allogene Therapeutics, Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.15
Actual
-$0.15
Surprise
+0.33%
Arcturus Therapeutics Holdings Inc. Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.69
Actual
-$0.26
Surprise
+62.44%
Anika Therapeutics Inc
Report Date
Nov 06, 2026 For Q3 26
Estimate
$0.06
Actual
$0.28
Surprise
+373.86%
Moderna, Inc. Common Stock
Report Date
Nov 06, 2026 For Q3 26
Estimate
-$1.27
Actual
$0.38
Surprise
+129.79%
Vera Therapeutics, Inc. Class A Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$1.65
Actual
-$1.30
Surprise
+21.33%
FAQ
What were Immunocore Holdings plc - ADR's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Immunocore Holdings plc - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Immunocore Holdings plc - ADR's Q3 2026 earnings?
The stock price moved down -2.66%, changed from $30.03 before the earnings release to $29.23 the day after.
When is Immunocore Holdings plc - ADR expected to report next?
The next earning report is scheduled for Feb 23, 2027.
What are the forecasts for Immunocore Holdings plc - ADR's next earnings report?
Based on 11
analysts, Immunocore Holdings plc - ADR is expected to report EPS of -$0.17 and revenue of $119.19M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.